Search results
Showing 61 to 75 of 207 results for arthritis
Cellulitis and erysipelas: antimicrobial prescribing (NG141)
This guideline sets out an antimicrobial prescribing strategy for adults, young people, children and babies aged 72 hours and over with cellulitis and erysipelas. It aims to optimise antibiotic use and reduce antibiotic resistance.
Summary of the evidence on rituximab (MabThera) for treating skin involvement in systemic sclerosis to inform local NHS planning and decision-making
Fever in under 5s: assessment and initial management (NG143)
This guideline covers the assessment and early management of fever with no obvious cause in children aged under 5. It aims to improve clinical assessment and help healthcare professionals diagnose serious illness among young children who present with fever in primary and secondary care.
Deucravacitinib for treating active psoriatic arthritis TS ID 11981
Awaiting development [GID-TA11510] Expected publication date: TBC
people with persistent peripheral spondyloarthritis (excluding psoriatic arthritis) or undifferentiated spondyloarthritis? Any...
Evidence on the safety and efficacy of midcarpal hemiarthroplasty for wrist arthritis is inadequate in quantity and quality. Therefore,...
This indicator covers the practice can produce a register of people with moderate to severe frailty. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM185
A quick and easy-to-read guide for care home managers about achieving good oral health in care homes.
therapeutic monitoring of TNF‑alpha inhibitors in people with rheumatoid arthritis. Any explanatory notes(if applicable) Source guidance
Spesolimab for treating generalised pustular psoriasis flares [ID3963]
In development [GID-TA10871] Expected publication date: 19 March 2025
monitoring of tumour necrosis factor (TNF)‑alpha inhibitors in rheumatoid arthritis Any explanatory notes(if applicable) Source guidance...
Evidence-based recommendations on secukinumab (Cosentyx) for treating active ankylosing spondylitis that has not responded well enough to conventional therapy.
within registries of patients receiving biological treatments for psoriatic arthritis to obtain information on long-term outcomes,...
distal radioulnar joint replacement for symptomatic joint instability or arthritis should provide information on patient selection, and...
non-steroidal antiinflammatory drugs (NSAIDs) in adults with rheumatoid arthritis (RA) whose pain or stiffness control is not adequate?...